a public good project by the
Synthesis
Company
of California

© 2026

Yang Hong | doi.page

0 works0 citations0 h-index

Yang Hong

Peking University(CN)Peking University People's Hospital(CN)

Publications by Year

Research Areas

Gastric Cancer Management and Outcomes, Metastasis and carcinoma case studies, Lung Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research, Bladder and Urothelial Cancer Treatments

Most-Cited Works

→ Hematopoietic and lymphatic cancers in patients with periodontitis: a systematic review and meta-analysis(2019)21 cited
→ Overexpression of COPS3 promotes clear cell renal cell carcinoma progression via regulation of Phospho-AKT(Thr308), Cyclin D1 and Caspase-3(2018)16 cited
→ Knockdown of COPS3 inhibits the progress of prostate cancer through reducing phosphorylated p38 MAPK expression and impairs the epithelial‐mesenchymal transition process(2019)9 cited
→ Prostate Cancer Risk and Prognostic Influence Among Users of 5-Alpha-Reductase Inhibitors and Alpha-Blockers: A Systematic Review and Meta-Analysis(2020)8 cited
→ Prognostic nomogram for overall survival in upper urinary tract urothelial carcinoma (UTUC) patients treated with chemotherapy: a SEER-based retrospective cohort study(2023)8 cited
[Efficacy evaluation of laparoscopy-assisted radical gastrectomy in obese patients with gastric cancer].(2014)

→ Effect of phosphodiesterase type 5 inhibitors on prostate cancer risk and biochemical recurrence after prostate cancer treatment: A systematic review and meta-analysis(2018)

4 cited

→ circRNA TATA‐box binding protein associated factor 15 acts as an oncogene to facilitate bladder cancer progression through targeting miR‐502‐5p/high mobility group box 3(2024)4 cited

EFL Learners` Perceptions of Pronunciation, Pronunciation Anxiety, and Pronunciation Learning Strategies(2016)

→ Composition analysis of renal and ureteral calculi in a single center in northern China in the past decade(2024)4 cited